EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

EAST RUTHERFORD, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), ...

In this free webinar, learn how crystallization strategies can optimize API development and scale-up. Attendees will understand the importance of crystallization in API development and manufacturing.

Technological advancements in synthetic chemistry, bioproduction, and containment are enhancing the feasibility of developing potent therapeutics. Regulatory scrutiny and environmental, safety, and ...

—The Noramco Group Addresses Critical Supply Chain Challenges, Offering Comprehensive Active Pharmaceutical Ingredients (API) and Drug Product Solutions— WILMINGTON, Del.--(BUSINESS WIRE)--Noramco, a ...

GERMANTOWN, Wis.--(BUSINESS WIRE)--AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge ...

RIVERVIEW, Michigan, Dec. 8, 2020 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), today announced plans to ...

Pharmaceutical companies have historically relied on in-house capabilities for API discovery, development, and manufacturing. However, the last few decades have seen a shift towards outsourcing these ...

SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a ...